Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation.

Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD.

BMC Immunol. 2012 Jan 31;13:6. doi: 10.1186/1471-2172-13-6.

2.

B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance.

Su Y, Zhang AH, Noben-Trauth N, Scott DW.

Front Microbiol. 2011 Jul 15;2:154. doi: 10.3389/fmicb.2011.00154. eCollection 2011.

4.
5.

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA.

J Exp Med. 2003 Dec 1;198(11):1741-52.

6.

The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.

Noben-Trauth N, Lira R, Nagase H, Paul WE, Sacks DL.

J Immunol. 2003 May 15;170(10):5152-8.

7.

The immunology of susceptibility and resistance to Leishmania major in mice.

Sacks D, Noben-Trauth N.

Nat Rev Immunol. 2002 Nov;2(11):845-58. Review.

PMID:
12415308
8.
9.

Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells.

Schüler T, Kammertoens T, Preiss S, Debs P, Noben-Trauth N, Blankenstein T.

J Exp Med. 2001 Dec 17;194(12):1767-75.

10.

Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites.

Urban JF Jr, Noben-Trauth N, Schopf L, Madden KB, Finkelman FD.

J Immunol. 2001 Dec 1;167(11):6078-81.

11.

Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells.

Payet-Jamroz M, Helm SL, Wu J, Kilmon M, Fakher M, Basalp A, Tew JG, Szakal AK, Noben-Trauth N, Conrad DH.

J Immunol. 2001 Apr 15;166(8):4863-9.

12.

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.

Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA.

Nat Immunol. 2000 Dec;1(6):515-20.

PMID:
11101874
13.

IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6.

Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, Izumi S, Okamura H, Paul WE, Nakanishi K.

Nat Immunol. 2000 Aug;1(2):132-7.

PMID:
11248805
14.

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

McGaha T, Saito S, Phelps RG, Gordon R, Noben-Trauth N, Paul WE, Bona C.

J Invest Dermatol. 2001 Jan;116(1):136-43.

15.

Susceptibility to Leishmania major infection in the absence of IL-4.

Noben-Trauth N.

Immunol Lett. 2000 Dec 1;75(1):41-4. Review.

PMID:
11163865
16.

A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes.

Radu DL, Noben-Trauth N, Hu-Li J, Paul WE, Bona CA.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12700-4.

17.

Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation.

Noben-Trauth N, Hu-Li J, Paul WE.

J Immunol. 2000 Oct 1;165(7):3620-5.

19.
20.

Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.

Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM, Cheever AW, Paul WE, Sher A.

J Immunol. 1999 Jul 1;163(1):337-42.

21.
23.

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice.

Schüler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T.

J Exp Med. 1999 Mar 1;189(5):803-10.

24.
25.

IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis.

Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD.

Immunity. 1998 Feb;8(2):255-64.

26.

An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

Noben-Trauth N, Shultz LD, Brombacher F, Urban JF Jr, Gu H, Paul WE.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10838-43.

27.

Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.

Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB.

J Immunol. 1997 Sep 15;159(6):2911-21.

PMID:
9300715
28.

CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression.

Wang R, Fang Q, Zhang L, Radvany L, Sharma A, Noben-Trauth N, Mills GB, Shi Y.

J Immunol. 1997 Mar 15;158(6):2856-61.

PMID:
9058822
29.

The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice.

Metwali A, Elliott D, Blum AM, Li J, Sandor M, Lynch R, Noben-Trauth N, Weinstock JV.

J Immunol. 1996 Nov 15;157(10):4546-53.

PMID:
8906833
30.

Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse.

Morawetz RA, Gabriele L, Rizzo LV, Noben-Trauth N, Kühn R, Rajewsky K, Müller W, Doherty TM, Finkelman F, Coffman RL, Morse HC 3rd.

J Exp Med. 1996 Nov 1;184(5):1651-61.

31.

Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.

Noben-Trauth N, Köhler G, Bürki K, Ledermann B.

Transgenic Res. 1996 Nov;5(6):487-91.

PMID:
8840532
32.

Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3.

Schweitzer PA, Noben-Trauth N, Pelsue SC, Johnson KR, Wolf SF, Shultz LD.

Mamm Genome. 1996 May;7(5):394-5. No abstract available.

PMID:
8661735
33.

The interleukin-12 beta subunit (p40) maps to mouse chromosome 11.

Noben-Trauth N, Schweitzer PA, Johnson KR, Wolf SF, Knowles BB, Shultz LD.

Mamm Genome. 1996 May;7(5):392. No abstract available.

PMID:
8661733
34.

Susceptibility to Leishmania major infection in interleukin-4-deficient mice.

Noben-Trauth N, Kropf P, Müller I.

Science. 1996 Feb 16;271(5251):987-90.

PMID:
8584936

Supplemental Content

Loading ...
Support Center